Stock

Moderna CEO confident of producing 500 million COVID-19 vaccine doses in 2021

(Reuters) – Moderna (NASDAQ:MRNA) Inc will be able to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Executive Officer Stéphane Bancel said on Friday

“For 500 million, I am very comfortable we are gonna get there (2021),” Bancel said, while speaking at the Nasdaq Investor Conference.

The CEO said the company will be able to maintain a premium price of $37 for its vaccine doses.

“For big volume supplies like to the U.S. government we can maintain $25 for doses”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s